Brian Burkavage

Controller, Passage BIO, Inc.

Companies

Damora Therapeutics, Inc.SVP, Finance May 8, 2026 to now¹
IO Biotech, Inc.Chief Accounting Officer May 13, 2022 to now²
Passage BIO, Inc.Controller Jun 9, 2021 to Jun 9, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

IO Biotech, Inc.11,500 shares⁴Nov 22, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 22, 2023Bought 5,000 shares at $1.04 of IO Biotech, Inc.⁴
Nov 21, 2023Bought 5,000 shares at $0.99 of IO Biotech, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDamora Therapeutics, Inc., SVP, Finance
2
SEC EDGARIO Biotech, Inc., Chief Accounting Officer
3
SEC EDGARPassage BIO, Inc., Controller
4
SEC EDGARIO Biotech, Inc. shares after the filing of Nov 22, 2023